drugset / Trial / NCT02131636
Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the safety and efficacy of AGN-199201 once daily compared to vehicle for the treatment of persistent moderate to severe facial erythema associated with rosacea.
Timeline
- Start
- 2014-05
- Primary completion
- 2014-11
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxymetazoline | Other / unclassified | — | Topical |